Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocols.
van Grotel M, Meijerink JP, Beverloo HB, Langerak AW, Buys-Gladdines JG, Schneider P, Poulsen TS, den Boer ML, Horstmann M, Kamps WA, Veerman AJ, van Wering ER, van Noesel MM, Pieters R. van Grotel M, et al. Among authors: van noesel mm, van wering er. Haematologica. 2006 Sep;91(9):1212-21. Haematologica. 2006. PMID: 16956820
Renin-induced hypertension in Wilms tumor patients.
Maas MH, Cransberg K, van Grotel M, Pieters R, van den Heuvel-Eibrink MM. Maas MH, et al. Among authors: van grotel m, van den heuvel eibrink mm. Pediatr Blood Cancer. 2007 May;48(5):500-3. doi: 10.1002/pbc.20938. Pediatr Blood Cancer. 2007. PMID: 16794999
Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences.
van Grotel M, Meijerink JP, van Wering ER, Langerak AW, Beverloo HB, Buijs-Gladdines JG, Burger NB, Passier M, van Lieshout EM, Kamps WA, Veerman AJ, van Noesel MM, Pieters R. van Grotel M, et al. Among authors: van noesel mm, van wering er, van lieshout em. Leukemia. 2008 Jan;22(1):124-31. doi: 10.1038/sj.leu.2404957. Epub 2007 Oct 11. Leukemia. 2008. PMID: 17928886
The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia.
Van Vlierberghe P, van Grotel M, Beverloo HB, Lee C, Helgason T, Buijs-Gladdines J, Passier M, van Wering ER, Veerman AJ, Kamps WA, Meijerink JP, Pieters R. Van Vlierberghe P, et al. Among authors: van grotel m, van wering er. Blood. 2006 Nov 15;108(10):3520-9. doi: 10.1182/blood-2006-04-019927. Epub 2006 Jul 27. Blood. 2006. PMID: 16873670 Free article.
Anti-GD2 Based Immunotherapy Prevents Late Events in High-Risk Neuroblastoma Patients over 18 Months at Diagnosis.
Tas ML, Dootjes LW, Fiocco M, de Krijger RR, Dierselhuis MP, van Eijkelenburg NKA, van Grotel M, Kraal KCJM, Peek AML, Tytgat GAM, van Noesel MM. Tas ML, et al. Among authors: van grotel m, van eijkelenburg nka, van noesel mm. Cancers (Basel). 2021 Sep 30;13(19):4941. doi: 10.3390/cancers13194941. Cancers (Basel). 2021. PMID: 34638426 Free PMC article.
Treatment-Related Toxicities During Anti-GD2 Immunotherapy in High-Risk Neuroblastoma Patients.
Blom T, Lurvink R, Aleven L, Mensink M, Wolfs T, Dierselhuis M, van Eijkelenburg N, Kraal K, van Noesel M, van Grotel M, Tytgat G. Blom T, et al. Among authors: van grotel m, van noesel m, van eijkelenburg n. Front Oncol. 2021 Feb 17;10:601076. doi: 10.3389/fonc.2020.601076. eCollection 2020. Front Oncol. 2021. PMID: 33680926 Free PMC article.
78 results